This trust offers the following services:

• Diagnostic and pre-operative services:
• On-site MRI liver facilities
• On-site Cardio-Pulmonary Exercise Testing (CPET) facilities
• Age Specific Genetic Testing for Lynch Syndrome

• Oncology services:
• On-site chemotherapy services

• Advanced disease services:
• Extended lymphadenectomy

• Support service facilities:
• Availability of 24 hour palliative care advice

All Patients:	Trust	Network	National
Number of patients in Audit	223	2011	29766
Case ascertainment (%)	121	99	90
Data completeness of:
– Pre-treatment TNM (%)	86	75	83
– Performance status (%)	74	77	85

Patients having major resection:	Trust	Network	National
Number of patients in Audit	123	1128	16499
ASA grade 1 (%)	2	8	10
ASA grade 2 (%)	27	48	53
ASA grade 3 (%)	21	33	30
ASA grade 4+ (%)	3	4	3
ASA grade not recorded (%)	46	8	4
Data completeness of:
7 Audit items for risk-adjustment (%)	54	77	86

All Patients:	Trust	Network	National
Number of patients in Audit	223	2011	29766
Seen by Clinical Nurse Specialist (%)	92	82	86

All patients deemed potentially curative	Trust	Network	National
Number of potentially curative patients	76	523	7226
Undergoing major resection (%)	97	85	86

Patients having major resection:	Trust	Network	National
Number of patients in Audit	123	1128	16474
Distant metastases (%)	5	5	6
Urgent or emergency surgery (%)	14	15	15
At least 12 lymph nodes excised (%)	89	74	84
Laparoscopic surgery attempted (%)	98	85	72
Risk-adjusted length of stay > 5 days (%)	47	52	62

Patients having major resection for stage III colon cancer:	Trust	Network	National
Number of patients in audit	71	692	10641
Adjuvant chemotherapy (%)	75	58	61

Patients having major resection:	Trust	Network	National
Number of patients in Audit	29	279	3899
Neoadjuvant therapy (%)	30	32	32
Circumferential resection margin: Recorded (%)	97	73	86
Circumferential resection margin: Negative (%)	97	70	79
Rectal volume	N/A	N/A	N/A

Patients in APER/Hartmanns estimate:	Trust	Network	National
Number of patients in APER/Hartmanns estimate	N/A	N/A	N/A
APER/Hartmanns (%)	N/A	N/A	N/A